Indeed, VBIT-12 was found to efficiently prevent acantholysis due to PV IgG/AK23.<h4>Conclusions</h4>Our findings identify VDAC as a novel factor in the pathogenesis of PV and thus as an innovative and attractive therapeutic target for the treatment of this disease. This evidence concerns the gene VDAC1 and acquired polycythemia vera.